- Home
- NERV vs BNZI Comparison
NERV vs BNZI Comparison
Compare NERV & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- BNZI
- Stock Information
- Founded
- NERV 2007
- BNZI 2016
- Country
- NERV United States
- BNZI United States
- Employees
- NERV N/A
- BNZI N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- BNZI
- Sector
- NERV Health Care
- BNZI
- Exchange
- NERV Nasdaq
- BNZI Nasdaq
- Market Cap
- NERV 10.3M
- BNZI 9.5M
- IPO Year
- NERV 2014
- BNZI N/A
- Fundamental
- Price
- NERV $1.78
- BNZI $1.00
- Analyst Decision
- NERV Hold
- BNZI Strong Buy
- Analyst Count
- NERV 1
- BNZI 1
- Target Price
- NERV $5.00
- BNZI $125.00
- AVG Volume (30 Days)
- NERV 18.1K
- BNZI 1.2M
- Earning Date
- NERV 05-05-2025
- BNZI 04-15-2025
- Dividend Yield
- NERV N/A
- BNZI N/A
- EPS Growth
- NERV N/A
- BNZI N/A
- EPS
- NERV 0.19
- BNZI N/A
- Revenue
- NERV N/A
- BNZI $4,527,879.00
- Revenue This Year
- NERV N/A
- BNZI $430.54
- Revenue Next Year
- NERV N/A
- BNZI N/A
- P/E Ratio
- NERV $9.00
- BNZI N/A
- Revenue Growth
- NERV N/A
- BNZI N/A
- 52 Week Low
- NERV $1.15
- BNZI $0.74
- 52 Week High
- NERV $3.69
- BNZI $20.50
- Technical
- Relative Strength Index (RSI)
- NERV 59.64
- BNZI 44.23
- Support Level
- NERV $1.52
- BNZI $0.92
- Resistance Level
- NERV $1.81
- BNZI $1.25
- Average True Range (ATR)
- NERV 0.17
- BNZI 0.11
- MACD
- NERV 0.04
- BNZI 0.01
- Stochastic Oscillator
- NERV 95.45
- BNZI 28.57
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.